Improving Maternal Nutrition in Matlab (IMNiM)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04868669 |
|
Recruitment Status :
Active, not recruiting
First Posted : May 3, 2021
Last Update Posted : May 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background: Maternal undernutrition and inadequate gestational weight gain (GWG) are prevalent in rural communities of low- and middle-income countries (LMICs). In Matlab, Bangladesh, 54% of the women fail to gain adequate weight (>4 kg) in the third trimester. Risks associated with inadequate GWG include giving birth to a small-for-gestational age (SGA) infant, low birth weight (LBW) infant, preterm birth (PTB), etc. Few contemporary studies examined the efficacy of nutrition counseling on GWG improvement in LMICs.
Objectives: The primary objective of this study is to assess whether in-home, intensive nutrition counseling during pregnancy, compared to standard antenatal care, could improve GWG among pregnant women in rural Bangladesh.
Methods: This prospective, two-arm, parallel group, equal allocation, open-label, community-based, cluster-randomized controlled trial will be conducted in the icddr,b service area of Matlab, a rural subdistrict of Bangladesh. Clusters will be randomly allocated 1:1 to the intervention arm in which pregnant women will receive monthly in-home, intensive nutrition counseling or the control arm in which pregnant women will receive standard antenatal care as offered by icddr,b and Govt. facilities. Fixed Site Clinics (FSCs) located at the homes of the community health research workers (CHRWs) will act as clusters. Of the 33 FSCs serving rural areas in the icddr,b service area, 20 will be selected randomly and listed. These 20 clinics will then be randomly allocated 1:1 to either an intervention or control group using a computer-generated random allocation sequence. To fulfil the required sample size, each selected CHRW will enroll 16 consecutive pregnancies. Required sample size is 16 women per cluster i.e. 160 women per arm. Eligible participants will be enrolled upon obtaining their consent by 13 and 6/7 weeks of gestation (first trimester) and followed up to 6 weeks postpartum. Trained health workers will visit the homes of the women in the intervention arm once a month and provide nutrition counseling to the women and her influential family members such as mothers, mothers-in-law and husbands. Both intention-to-treat and per-protocol analyses will be performed.
Outcome measures/variables: Proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to the US Institute of Medicine (IOM) 2009 guidelines is the primary outcome variable.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Gestational Weight Gain | Behavioral: In-home, intensive nutrition counseling | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 287 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | prospective, two-arm, parallel-group, equal allocation, open-label, community-based, cluster-randomized controlled trial |
| Masking: | None (Open Label) |
| Masking Description: | In this study, the blinding of the intervention is not feasible. However, the outcomes of the trial are objective in nature. Furthermore, the randomization and the statistical analysis will be carried out by someone unconnected to the allocation and enrollment process. |
| Primary Purpose: | Health Services Research |
| Official Title: | In-home, Intensive Nutrition Counseling to Improve Gestational Weight Gain in Rural Bangladesh: A Cluster-Randomized Controlled Trial |
| Actual Study Start Date : | January 15, 2020 |
| Estimated Primary Completion Date : | September 30, 2021 |
| Estimated Study Completion Date : | October 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention
In this arm, pregnant women, along with their influential family members such as mothers, mothers-in-law, and husbands, will receive monthly in-home, intensive nutrition counseling during the prenatal period.
|
Behavioral: In-home, intensive nutrition counseling
|
|
No Intervention: Control
Pregnant women in this arm will receive standard antenatal care.
|
- proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to IOM 2009 guidelines [ Time Frame: Pre-delivery ]Pregnancy trimesters are defined as follows: 1st trimester (0 weeks - 13+6 weeks), 2nd trimester (14 completed weeks - 27+6 weeks), and 3rd trimester (28 completed weeks - childbirth). Rate of weight gain between two time points (trimesters) will be calculated by subtracting the weight measured at the first time point from the weight measured at the second time point and dividing the derived value by the difference in weeks between the two time points.
- total gestational weight gain (kg) [ Time Frame: pre-delivery ]
- rate of weight gain during the 2nd and 3rd trimester (kg/week) [ Time Frame: pre-delivery ]
- proportion of women with inadequate total GWG according to IOM criteria [ Time Frame: pre-delivery ]
- proportion of women with inadequate total GWG according to local criteria [ Time Frame: pre-delivery ]
- proportion of women with inadequate third trimester weight gain according to local criteria [ Time Frame: pre-delivery ]
- proportion of preterm births [ Time Frame: at delivery ]childbirth before 37 completed weeks
- maternal mid-upper arm circumference (MUAC) (mm) [ Time Frame: baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum ]
- maternal weight (kg) [ Time Frame: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum ]
- maternal body mass index (BMI) (kg/m^2) [ Time Frame: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum ]weight and height (at baseline) will be combined to report BMI
- infant weight (g) [ Time Frame: at birth (delivery) and after 4 weeks ]
- infant length (cm) [ Time Frame: at birth (delivery) and after 4 weeks ]
- infant head circumference (cm) [ Time Frame: at birth (delivery) and after 4 weeks ]
- proportion of low birth weight (< 2500 g) infants [ Time Frame: at birth (delivery) ]
- proportion of small for gestational age (<10th percentile) infants according to Intergrowth-21st standards [ Time Frame: at birth (delivery) ]
- proportion of women with pregnancy complications e.g. anemia, preeclampsia [ Time Frame: at delivery ]
- proportion of women with obstetric complications e.g. induction of labor, caesarean section [ Time Frame: at delivery ]
- newborn Apgar score [ Time Frame: at birth (delivery) ]
- proportion of infants developing morbidity [ Time Frame: 4 weeks after birth ]
- proportion of infant mortality [ Time Frame: 4 weeks after birth ]
- dietary diversity score according to the "Guidelines for Measuring Household and Individual Dietary Diversity" [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]score range: 0-9; higher scores indicate a better outcome
- dietary diversity score according to the "Minimum Dietary Diversity for Women: A Guide to Measurement" [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]score range: 0-10; higher scores indicate a better outcome
- proportion of women with inadequate dietary diversity accroding to the "Minimum Dietary Diversity for Women: A Guide to Measurement" [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]score range: 0-10; <5 indicates inadequate dietary diversity
- energy consumption (kcal) [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]
- protein consumption (g) [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]
- proportion of women with symptoms of depression as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
- proportion of women with symptoms of anxiety as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
- proportion of women with symptoms of stress as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales [ Time Frame: baseline, 36 weeks of gestation and 6 weeks post-partum ]DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
- healthcare seeking and services utilization e.g. number of prenatal visits [ Time Frame: at delivery ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 39 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | This trial will focus on improving gestational weight gain in pregnant women. Hence, all the study participants are pregnant women. |
| Accepts Healthy Volunteers: | Yes |
Pregnant women permanently residing in the icddr,b service area of Matlab fulfilling the following criteria:
Inclusion Criteria:
- aged 18-39 years
- in the first trimester of pregnancy (before 14 weeks of gestation)
- BMI 16-24.99 kg/m^2 measured on enrollment
- willing to participate in the study
Exclusion criteria
- multiple pregnancy (carrying two or more fetuses)
- threatened abortion, persistent pervaginal bleeding, or cervical incompetence
- history of three or more consecutive abortions
- history of gestational diabetes, macrosomia, gestational hypertension, preeclampsia/eclampsia in a prior pregnancy
- chronic diseases, such as hypertension, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, pancreatic diseases, Crohn's disease, ulcerative colitis, diabetes mellitus, thyroid dysfunction, immunological diseases, malignancy or any other diseases which could impede compliance with the study protocol
- taking medications known to influence fetal growth, such as insulin, thyroid hormones, glucocorticoids
- known case of serious psychiatric or behavioral disorders, such as schizophrenia, bipolar disorder
- scored as moderate or worse on enrollment on any one of the subscales of the Depression, Anxiety and Stress Scales-21 (DASS-21)
- inability to read or write Bengali
- belonging to moderately or severely food insecure households as measured by the Household Food Insecurity Access Scale (HFIAS)
- having a plan to move or deliver outside the study area
- women practicing some form of vegetarianism
- women belonging to a household from which another woman is already enrolled in the study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04868669
| Bangladesh | |
| International Centre for Diarrhoeal Disease Research, Bangladesh | |
| Chandpur, Bangladesh | |
| Principal Investigator: | S. M. Tafsir Hasan, MBBS, MS | Nutrition and Clinical Services Division, icddr,b |
| Responsible Party: | International Centre for Diarrhoeal Disease Research, Bangladesh |
| ClinicalTrials.gov Identifier: | NCT04868669 |
| Other Study ID Numbers: |
PR-19109 |
| First Posted: | May 3, 2021 Key Record Dates |
| Last Update Posted: | May 3, 2021 |
| Last Verified: | April 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
nutrition counseling gestational weight gain cluster randomized controlled trial birth weight |
|
Weight Gain Gestational Weight Gain Body Weight Body Weight Changes |

